Peter A Nigrovic Selected Research

Vasculitis (Vasculitides)

1/2023	Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2.
1/2020	Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter A Nigrovic Research Topics

Disease

33	Arthritis (Polyarthritis) 02/2024 - 03/2006
26	Inflammation (Inflammations) 12/2023 - 01/2005
22	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2024 - 01/2008
12	Rheumatoid Arthritis 10/2023 - 05/2008
7	Macrophage Activation Syndrome 11/2023 - 01/2018
6	Experimental Arthritis 11/2016 - 01/2009
3	Exanthema (Rash) 10/2023 - 01/2008
3	Uveitis 01/2022 - 01/2019
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 09/2012
3	Autoimmune Diseases (Autoimmune Disease) 10/2019 - 06/2013
3	Rheumatic Diseases (Rheumatism) 01/2018 - 03/2012
3	Synovitis 12/2016 - 04/2006
2	Eosinophilia 10/2023 - 10/2023
2	Lung Diseases (Lung Disease) 10/2023 - 01/2022
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 08/2023 - 06/2006
2	Vasculitis (Vasculitides) 01/2023 - 01/2020
2	Pure Red-Cell Aplasia 01/2023 - 01/2020
2	Ankylosing Spondylitis 08/2022 - 04/2022
2	Necrosis 01/2022 - 10/2016
2	Lyme Disease (Disease, Lyme) 10/2021 - 05/2014
2	Peritonitis 12/2019 - 07/2014
2	Fever (Fevers) 02/2019 - 02/2011
2	Sacroiliitis 01/2019 - 01/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2018 - 06/2013
2	Disease Progression 11/2016 - 02/2011
2	Infections 07/2014 - 05/2013
2	Tuberculosis (Tuberculoses) 10/2013 - 10/2013
1	Adult-Onset Still's Disease 01/2024
1	Down Syndrome (Down's Syndrome) 10/2023
1	Anaphylaxis (Anaphylactic Shock) 10/2023
1	Drug Hypersensitivity (Drug Allergy) 10/2023
1	Aneurysm (Aneurysms) 08/2023
1	Simian Acquired Immunodeficiency Syndrome 01/2023
1	Burns 01/2023
1	Genetic Risk Score 04/2022
1	Pain (Aches) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Drug Hypersensitivity Syndrome 01/2022
1	Gout 01/2022
1	Hyperuricemia 01/2022

Drug/Important Bio-Agent (IBA)

15	AutoantibodiesIBA 01/2022 - 03/2006
11	Interleukin-1 (Interleukin 1)IBA 10/2023 - 02/2007
8	CytokinesIBA 10/2023 - 01/2005
8	AntigensIBA 01/2023 - 03/2006
7	Immunoglobulin G (IgG)IBA 10/2021 - 11/2010
6	Methotrexate (Mexate)FDA LinkGeneric 10/2023 - 03/2012
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2012
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2018
4	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 10/2016
4	AntibodiesIBA 01/2020 - 03/2006
4	Complement System Proteins (Complement)IBA 01/2019 - 06/2006
4	Antigen-Antibody Complex (Immune Complex)IBA 01/2019 - 11/2010
4	AutoantigensIBA 12/2016 - 06/2013
3	Interferon-gamma (Interferon, gamma)IBA 12/2023 - 01/2022
3	Interferon Type IIBA 11/2023 - 10/2016
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 10/2016
3	Leukotriene B4IBA 01/2023 - 04/2006
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 08/2022 - 01/2008
3	Adalimumab (Humira)FDA Link 01/2022 - 01/2019
3	GlucocorticoidsIBA 01/2019 - 01/2018
3	Polysaccharides (Glycans)IBA 12/2017 - 03/2012
3	CollagenIBA 01/2016 - 06/2007
2	TNF Receptor-Associated Factor 1IBA 02/2024 - 11/2023
2	Interleukin-17 (Interleukin 17)IBA 08/2023 - 11/2019
2	chlorotriphenylsilane (CTPS)IBA 12/2022 - 04/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2022 - 05/2017
2	EnzymesIBA 10/2021 - 01/2020
2	pristane (pristan)IBA 10/2020 - 01/2019
2	InterferonsIBA 01/2020 - 09/2012
2	Ferritins (Ferritin)IBA 02/2019 - 02/2011
2	Infliximab (Remicade)FDA Link 01/2019 - 01/2019
2	Monoclonal AntibodiesIBA 01/2019 - 01/2019
2	Glycoproteins (Glycoprotein)IBA 05/2017 - 01/2010
2	Chemokine ReceptorsIBA 01/2016 - 01/2009
2	Interleukin-33IBA 07/2014 - 01/2012
2	Antinuclear AntibodiesIBA 05/2014 - 09/2012
2	Peptides (Polypeptides)IBA 06/2013 - 03/2012
2	Fc Receptors (Fc Receptor)IBA 09/2012 - 03/2010
2	ProstaglandinsIBA 09/2012 - 05/2008
2	Anaphylatoxin C5a ReceptorIBA 11/2010 - 03/2010
2	Tryptases (Tryptase)IBA 07/2010 - 01/2009
2	LeukotrienesIBA 03/2010 - 04/2006
1	ChromatinIBA 12/2023
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2023
1	Transcription Factors (Transcription Factor)IBA 12/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2023
1	LuciferasesIBA 11/2023
1	Interleukin-6 InhibitorsIBA 10/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2023
1	Janus Kinase InhibitorsIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 04/2022
1	ProteomeIBA 01/2022
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022
1	methylglyoxal bis(butylamidinohydrazone)IBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022

Therapy/Procedure

15	Therapeutics 01/2024 - 02/2011
3	Biological Therapy 10/2023 - 01/2018
1	Lasers (Laser) 01/2023